Analysis reportAll specifications met
Ipamorelin 5mg
Peptide Stock ref. PSV-2610-IP05-01
Purity99.38%RP-HPLC, UV 214 nm
Content per vial5.23 mg104.6% of 5 mg label claim
IdentityConfirmedLC-MS (ESI+)
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity (LC-MS): Ipamorelin | Within ±1 Da of 711.868 Da | 711.935 Da | Pass |
| Purity (RP-HPLC 214 nm) | ≥ 99.25% | 99.38% | Pass |
| Net peptide content | Within ±10% of 5 mg | 5.23 mg (104.6% of claim) | Pass |
| Sterility (rapid PCR) | No microbial DNA detected | Not detected | Pass |
HPLC chromatogram
| Peak | Retention time | Area |
|---|---|---|
| 1 | 3.773 min | 0.151% |
| 2main | 4.167 min | 99.380% |
| 3 | 5.250 min | 0.469% |
About this report
- Sample received by the lab 6 October 2026; report issued 11 October 2026.
- 1 vial tested.
- Appearance as received: lyophilised powder.
- Results relate to the sample tested. For laboratory research use only.